Introducing

CuboPharm is dedicated to advancing therapeutic drug delivery through our patented Cubosome platform.

CuboPharm pioneers a patented cubosome platform that enhances bioavailability and improves patient safety. Our orally disintegrating tablets bypass first-pass metabolism, minimize toxic metabolite formation, and accommodate molecules up to 20 kDa. As leaders in next-generation therapies, we are dedicated to turning breakthrough science into transformative healthcare solutions across diverse therapeutic areas.